Nano Flow’s Anti-OXA gold conjugate is based on a monoclonal antibody targeting OXA-type carbapenemase, an important antimicrobial resistance marker in Gram-negative bacteria. Validated as a detection antibody in lateral flow assays, it ensures reliable and specific detection of OXA-producing bacteria. The corresponding capture antibody is also available, allowing developers to build optimized antibody pairs for rapid antimicrobial resistance diagnostics.
Anti-OXA Gold Conjugate – 40 nm (Ref NF-OXA-AU)
This conjugate demonstrates no cross-reactivity with other carbapenemases, ensuring diagnostic specificity. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it provides reproducibility, stability, and clear signal intensity in lateral flow and other immunoassay platforms.
Applications: Lateral flow assays (LF) and immunoassays for antimicrobial resistance detection.
Certificate of Analysis: Supplied with each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1 |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | OXA-type carbapenemase |
| Cross-reactivity | None with other carbapenemases |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
